Prognostic Significance of DSCC1, a Biomarker Associated with Aggressive Features of Breast Cancer

Prognostic Significance of DSCC1, a Biomarker Associated with Aggressive Features of Breast Cancer

<i>Background and Objectives</i>: Invasive breast cancer (BC) was traditionally investigated visually, and no technique could identify the key molecular drivers of patient survival. However, essential molecular drivers of invasive BC have now been discovered using innovative genomic, tra...

Full description

Saved in:

Bibliographic Details
Main Author:	Abrar I. Aljohani
Format:	Article
Language:	English
Published:	MDPI AG 2024-11-01
Series:	Medicina
Subjects:	DSSC1 invasive breast cancer prognosis
Online Access:	https://www.mdpi.com/1648-9144/60/12/1929
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Perivascular Invasion: A Promising Prognostic Parameter for Breast Cancer
by: Begüm Çalım GÜRBÜZ, et al.
Published: (2024-12-01)

SLC1A5 is a key regulator of glutamine metabolism and a prognostic marker for aggressive luminal breast cancer
by: Lutfi H. Alfarsi, et al.
Published: (2025-01-01)

Prognostic factors in hereditary breast cancer: A review
by: Ziske Maritska, et al.
Published: (2024-08-01)

Clinicopathological features and prognostic significance of TAF1L in gastric cancer
by: Han Chen, et al.
Published: (2024-12-01)

Race as a prognostic factor of breast mucinous carcinoma
by: Dingyuan Wang, et al.
Published: (2024-12-01)

Preoperative evaluation of red blood cell distribution width as a promising biomarker for discriminating between benign and malignant breast tumors and assessing breast cancer activity
by: Ajay Singh Thakur, et al.
Published: (2024-04-01)

Prognostic significance of lymphovascular invasion in pN0 stage gastric cancer: a propensity score matching analysis
by: Xuguang Jiao, et al.
Published: (2024-12-01)

Investigating the clinical significance of OAS family genes in breast cancer: an in vitro and in silico study
by: Jinjun Lu, et al.
Published: (2024-12-01)

SPP1 mRNA Expression Is Associated with M2 Macrophage Infiltration and Poor Prognosis in Triple-Negative Breast Cancer
by: Yu-Chia Chen, et al.
Published: (2024-11-01)

Construction and validation of a prognostic model for male breast cancer based on the SEER database
by: SU Xiaohan, et al.
Published: (2024-06-01)

Prognostic significance and identification of m6A regulator genes and hub genes associated with m6A in breast cancer
by: Longjie Xia, et al.
Published: (2024-11-01)

Mastectomy, HER2 Receptor Positivity, NPI, Late Stage and Luminal B-Type Tumor as Poor Prognostic Factors in Geriatric Patients with Breast Cancer
by: Demet Nak, et al.
Published: (2024-12-01)

Sarcopenia as a Prognostic Factor and Multimodal Interventions in Breast Cancer
by: Du L, et al.
Published: (2024-12-01)

Knockdown of HGH1 in breast cancer cell lines can inhibit the viability, invasion and migration of tumor cells
by: Zeyu Wang, et al.
Published: (2025-12-01)

Elevated ITGA3 expression serves as a novel prognostic biomarker and regulates tumor progression in cervical cancer
by: Wei Tan, et al.
Published: (2024-11-01)

The significance of risk stratification through nomogram-based assessment in determining postmastectomy radiotherapy for patients diagnosed with pT1 − 2N1M0 breast cancer
by: Chao Wei, et al.
Published: (2024-09-01)

CircRNAs as Possible Potential Biomarkers for Breast Cancer Prognosis and Chemotherapy Response: A Comprehensive Study
by: Saba Mirzaei, et al.
Published: (2024-10-01)

Construction of the bromodomain-containing protein-associated prognostic model in triple-negative breast cancer
by: Wei Chen, et al.
Published: (2025-01-01)

SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer
by: Linyan Ge, et al.
Published: (2025-01-01)

Erythrocyte modified controlling nutritional status as a biomarker for predicting poor prognosis in post-surgery breast cancer patients
by: Jingjing Hu, et al.
Published: (2025-01-01)

Functional Analysis and Experimental Validation of the Prognostic and Immune Effects of the Oncogenic Protein CDC45 in Breast Cancer
by: Zhang JN, et al.
Published: (2025-01-01)

Development and validation of a prognostic signature of breast cancer based on drug absorption, distribution, metabolism and excretion (ADME)-related genes
by: Zhixuan Wu, et al.
Published: (2024-09-01)

Unveiling the prognostic value of ARID3A in breast cancer through bioinformatic analysis
by: Wen-Run Cai, et al.
Published: (2025-02-01)

Bioinformatics insights into the role of GFPT1 in breast invasive carcinoma: implications for tumor prognosis, immune modulation, and therapeutic applications
by: Jianghui Liang, et al.
Published: (2024-11-01)

Psychological Stress and Its Correlations to Patients with Acute Lymphedema After Breast Cancer Surgery
by: Ge LP, et al.
Published: (2024-12-01)

Serum NLRP3 and S1P as Potential Diagnostic and Prognostic Biomarkers in Female Metastatic and Non-Metastatic Breast Cancer Patients
by: Anas R. Soltan, et al.
Published: (2023-12-01)

Integrative bioinformatics and immunohistochemical analysis unravel the prognostic significance and immunological implication of LIMCH1 in breast cancer: a retrospective study
by: Xin Yu, et al.
Published: (2025-01-01)

Performance Enhancement of Dye Sensitized Solar Cell (DSSC) through TiO2/rGO Hybrid: Comprehensive Study on Synthesis and Characterization
by: Rustan Hatib, et al.
Published: (2024-07-01)

Invasive micropapillary carcinoma of the breast and invasive breast carcinoma of no special type: a comparison of claudin proteins’ expression and its impact on survival
by: Zsófia Kramer, et al.
Published: (2024-12-01)

Pregnancy-associated breast cancer (PABC) in young women: a matched case-control study
by: Yanshou Zhang, et al.
Published: (2023-12-01)

Coagulation factor II thrombin receptor as a promising biomarker in breast cancer management
by: Dong Yan-Ming, et al.
Published: (2024-12-01)

Progress of phosphorylated proteomics in breast cancer
by: Yu-Jiao DENG, et al.
Published: (2020-12-01)

An overview of invasive micropapillary carcinoma of the breast: past, present, and future
by: Pu Qiu, et al.
Published: (2024-11-01)

CHST1 as a prognostic-related biomarker in gastric cancer correlating with immune infiltration
by: Long Gui, et al.
Published: (2025-02-01)

Chromatin licensing and DNA replication factor 1 as a potential prognostic and diagnostic biomarker for gastric cancer
by: Sijia Wang, et al.
Published: (2024-12-01)

Predicting breast cancer prognosis using PR and PIK3CA biomarkers: a comparative analysis of diagnostic groups
by: Yuting Feng, et al.
Published: (2025-01-01)

Incidence proportions and prognosis of breast cancer patients with bone metastases at initial diagnosis
by: Yue Gong, et al.
Published: (2018-08-01)

Tumor Suppressor miR-27a-5p and Its Significance for Breast Cancer
by: Paola Parrella, et al.
Published: (2024-11-01)

Low expression of WWC1, a tumor suppressor gene, is associated with aggressive breast cancer and poor survival outcome
by: Zhanwei Wang, et al.
Published: (2019-07-01)

Prognostic significance of PDCD1LG2 expression in pan-cancer and its relationship with the immune microenvironment
by: Quanxin Chen, et al.
Published: (2024-12-01)